4.7 Article

Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions

Journal

CIRCULATION RESEARCH
Volume 130, Issue 8, Pages 1204-1229

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.121.319949

Keywords

cerebral hemorrhage; epidemiology; hypertension; mortality; stroke

Funding

  1. American Heart Association Established Investigator Award
  2. National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [U01-NS062851, U01-NS080824, P01-NS092521, R01-NS107887]
  3. NIH/NINDS [P01-NS092521, R01-NS107887, R01NS095993, R01NS097728]
  4. American Heart Association (AHA) [2020AHA000BFCHS00199732]

Ask authors/readers for more resources

This review article provides an overview of the epidemiology, cause, mechanisms of injury, current treatment strategies, and future research directions of intracerebral hemorrhage (ICH). The incidence of hemorrhagic stroke has increased globally in the past 40 years, with changes in the cause over time due to improved hypertension management and increased use of anticoagulants. Preclinical and clinical trials have shed light on the underlying cause and mechanisms of injury from ICH, including the complex interaction between edema, inflammation, iron-induced injury, and oxidative stress. Although several trials have investigated the optimal medical and surgical management of ICH, there has been no clear improvement in survival and functional outcomes. Ongoing research into novel approaches for ICH management offers hope for reducing the devastating impact of this disease in the future.
Intracerebral hemorrhage (ICH) is a devastating form of stroke with high morbidity and mortality. This review article focuses on the epidemiology, cause, mechanisms of injury, current treatment strategies, and future research directions of ICH. Incidence of hemorrhagic stroke has increased worldwide over the past 40 years, with shifts in the cause over time as hypertension management has improved and anticoagulant use has increased. Preclinical and clinical trials have elucidated the underlying ICH cause and mechanisms of injury from ICH including the complex interaction between edema, inflammation, iron-induced injury, and oxidative stress. Several trials have investigated optimal medical and surgical management of ICH without clear improvement in survival and functional outcomes. Ongoing research into novel approaches for ICH management provide hope for reducing the devastating effect of this disease in the future. Areas of promise in ICH therapy include prognostic biomarkers and primary prevention based on disease pathobiology, ultra-early hemostatic therapy, minimally invasive surgery, and perihematomal protection against inflammatory brain injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)

Romuald Girard, Yan Li, Agnieszka Stadnik, Robert Shenkar, Nicholas Hobson, Sharbel Romanos, Abhinav Srinath, Thomas Moore, Rhonda Lightle, Abdallah Shkoukani, Amy Akers, Timothy Carroll, Gregory A. Christoforidis, James Koenig, Cornelia Lee, Kristina Piedad, Steven M. Greenberg, Helen Kim, Kelly D. Flemming, Yuan Ji, Issam A. Awad

Summary: The study aims to optimize biomarkers for accurate diagnosis of cerebral cavernous angioma with symptomatic hemorrhage (CASH), predict the risk of future hemorrhage, and monitor cases after bleeding and in response to therapy.

NEUROSURGERY (2021)

Article Hematology

Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage

Jessica Magid-Bernstein, Charles B. Beaman, Fernanda Carvalho-Poyraz, Amelia Boehme, Eldad A. Hod, Richard O. Francis, Mitchell S. Elkind, Sachin Agarwal, Soojin Park, Jan Claassen, E. Sander Connolly, David Roh

Summary: Acute platelet transfusion after intracerebral hemorrhage that is ABO-incompatible may lead to poorer platelet recovery and neurological outcomes compared to ABO-compatible transfusions. Further research into the underlying mechanisms is needed to better understand these observations.

BLOOD (2021)

Article Multidisciplinary Sciences

PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism

Aileen A. Ren, Daniel A. Snellings, Yourong S. Su, Courtney C. Hong, Marco Castro, Alan T. Tang, Matthew R. Detter, Nicholas Hobson, Romuald Girard, Sharbel Romanos, Rhonda Lightle, Thomas Moore, Robert Shenkar, Christian Benavides, M. Makenzie Beaman, Helge Mueller-Fielitz, Mei Chen, Patricia Mericko, Jisheng Yang, Derek C. Sung, Michael T. Lawton, J. Michael Ruppert, Markus Schwaninger, Jakob Koerbelin, Michael Potente, Issam A. Awad, Douglas A. Marchuk, Mark L. Kahn

Summary: Vascular malformations are caused by increased signaling through the PI3K-mTOR pathway and loss of function of the CCM complex, which are found in the majority of human CCMs. Using mouse models, researchers discovered that the formation of CCMs can be effectively blocked by the mTORC1 inhibitor rapamycin.

NATURE (2021)

Article Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome Symptoms, Incidence, and Resource Utilization in a Population-Based US Cohort

Jessica Magid-Bernstein, Setareh S. Omran, Neal S. Parikh, Alexander E. Merkler, Babak Navi, Hooman Kamel

Summary: The study estimated the age- and sex-standardized incidence of hospitalization for reversible cerebral vasoconstriction syndrome (RCVS) in US adults to be approximately 3 cases per million per year. Many patients with RCVS had concomitant neurologic diagnoses, including subarachnoid hemorrhage, ischemic stroke, and intracerebral hemorrhage.

NEUROLOGY (2021)

Article Clinical Neurology

Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials

Jessica R. Magid-Bernstein, Yunke Li, Sung-Min Cho, Pirouz J. Piran, David J. Roh, Ajay Gupta, Ashkan Shoamanesh, Alexander Merkler, Cenai Zhang, Radhika Avadhani, Nataly Montano, Constantino Iadecola, Guido J. Falcone, Kevin N. Sheth, Adnan Qureshi, Jonathan Rosand, Joshua Goldstein, Issam Awad, Daniel F. Hanley, Hooman Kamel, Wendy C. Ziai, Santosh B. Murthy

Summary: The study found that the presence of cerebral microbleeds (CMBs) is associated with smaller intracerebral hemorrhage (ICH) volume and lower odds of hematoma expansion among patients with acute hemorrhage. The strength of this association increases with the number of CMBs, indicating potential prognostic significance of underlying cerebral small vessel disease after ICH.

NEUROLOGY (2022)

Article Clinical Neurology

Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis

David J. Roh, Ifeyinwa S. Asonye, Fernanda Carvalho Poyraz, Jessica R. Magid-Bernstein, Evan F. Joiner, Radhika Avadhani, Issam Awad, Daniel F. Hanley, Wendy C. Ziai, Santosh B. Murthy

Summary: This study aimed to evaluate factors associated with intraventricular hemorrhage expansion and its impact on long-term outcomes. The authors found that acute hematoma characteristics, such as larger parenchymal volume, hematoma expansion, and thalamic intracerebral hemorrhage location, were associated with intraventricular hemorrhage expansion. Additionally, intraventricular hemorrhage expansion was associated with poor clinical outcomes. This study highlights the importance of optimizing hemostasis and preventing intraventricular hemorrhage expansion.

STROKE (2022)

Article Clinical Neurology

Emergent external ventricular drain placement in patients with factor Xa inhibitor-associated intracerebral hemorrhage after reversal with andexanet alfa

Abdalla A. Ammar, Aladine A. Elsamadicy, Mahmoud A. Ammar, Benjamin C. Reeves, Andrew B. Koo, Guido J. Falcone, David Y. Hwang, Nils Petersen, Jennifer A. Kim, Rachel Beekman, Morgan Prust, Jessica Magid-Bernstein, Julian N. Acosta, Ryan Herbert, Kevin N. Sheth, Charles C. Matouk, Emily J. Gilmore

Summary: This study compared the safety of immediate EVD placement after the bolus administration of a factor Xa-inhibitor reversal agent versus after the infusion of the agent in patients with intracerebral hemorrhage. The results showed no significant differences in the incidence of hemorrhage, mortality, length of hospital stay, and discharge modified Rankin Score between the two groups. Therefore, it may be considered to perform EVD placement immediately after the infusion of the reversal agent to shorten the treatment time.

CLINICAL NEUROLOGY AND NEUROSURGERY (2023)

Article Medicine, Research & Experimental

Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma

Abhinav Srinath, Bingqing Xie, Ying Li, Je Yeong Sone, Sharbel Romanos, Chang Chen, Anukriti Sharma, Sean Polster, Pieter C. Dorrestein, Kelly C. Weldon, Dorothy DeBiasse, Thomas Moore, Rhonda Lightle, Janne Koskimaki, Dongdong Zhang, Agnieszka Stadnik, Kristina Piedad, Matthew Hagan, Abdallah Shkoukani, Julian Carrion-Penagos, Dehua Bi, Le Shen, Robert Shenkar, Yuan Ji, Ashley Sidebottom, Eric Pamer, Jack A. Gilbert, Mark L. Kahn, Mark D'Souza, Dinanath Sulakhe, Issam A. Awad, Romuald Girard

Summary: Plasma metabolites can reflect the presence of CA and the occurrence of symptomatic hemorrhage, which is significant for the diagnosis and treatment of CA patients.

COMMUNICATIONS MEDICINE (2023)

Meeting Abstract Clinical Neurology

Proinflammatory Cytokines within the Cerebrospinal Fluid of Patients with Intraventricular Hemorrhage are Associated with Outcomes

Jessica Magid-Bernstein, Alison L. Herman, Conor Johnson, Hannah Beatty, Guido Falcone, Charles Matouk, Kevin Sheth, Lauren Sansing

ANNALS OF NEUROLOGY (2022)

Meeting Abstract Clinical Neurology

Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials

Jessica Magid-Bernstein, David Roh, Ajay Gupta, Ashkan Shoamanesh, Sung-Min Cho, Alexander Merkler, Radhika Avadhani, Joshua Gruber, Constantino Iadecola, Guido Falcone, Kevin Sheth, Adnan Qureshi, Joshua Goldstein, Jonathan Rosand, Daniel Hanley, Hooman Kamel, Wendy Ziai, Santosh Murthy

NEUROLOGY (2021)

Meeting Abstract Clinical Neurology

Red Blood Cell Transfusions and Associations with Outcome after Intracerebral Hemorrhage

Fernanda Carvalho Poyraz, Jessica Magid-Bernstein, Mitchell Elkind, Sachin Agarwal, Soojin Park, Jan Claassen, Eldad Hod, David Roh, E. Sander Connolly

NEUROLOGY (2021)

No Data Available